- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
- Is Gold in the Future for FBC Holding, Inc. (OTCQB: FBCD)?
- Will it be Clear Sailing for Alas International Holdings, Inc. (PINKSHEETS: VDSC)?
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tagsaapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks trading
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: fda approval
Shares of Dynavax Technologies Corp. (NASDAQ: DVAX) have been getting pounded on Friday following yesterday’s announcement that their lead product candidate HEPLISAV, an adult hepatitis B vaccine, failed to gain the support of an FDA advisory committee concerning safety issues. … Continue reading
After hitting a high of 1.83 just two days ago shares of Talon Therapeutics (OTCBB: TLON) have come crashing down, sinking as low as 0.81 on Wednesday and the bleeding may just be getting started. While TLON is less than … Continue reading
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) Receives Patent Allowance but FDA Approval for BEMA Buprenorphine Remains Critical
Less than two months ago shares of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) were trading at a 52-week low of 0.77 but the fortunes of the specialty pharmaceutical company that develops novel and proprietary patented drug delivery technologies has changed … Continue reading
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Acquires Diagnostic Technology for HPV but FDA Approval Remains a Hurdle Yet to be Cleared
With Allezoe Medical Holdings, Inc. (OTCBB: ALZM) announcing on Tuesday that they had acquired the exclusive license to develop and market patent pending, advanced “see and treat” diagnostic technology for Human papillomavirus (HPV), the world’s leading sexually transmitted infection, trading … Continue reading
Alexza Pharmaceuticals (NASDAQ: ALXA) Gaining Momentum on FDA Approval Recommendation Regarding ADASUVE
Following news that Alexza Pharmaceuticals (NASDAQ: ALXA) received recommendation for FDA approval from the Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) relating to their schizophrenia and bipolar mania treatment ADASUVE shares in the pharmaceutical … Continue reading
Is Cell Therapeutics, Inc. (NASDAQ: CTIC) Any Closer to FDA Approval for non-Hodgkin’s Lymphoma Drug Pixantrone?
The road to FDA approval for Cell Therapeutics, Inc. (NASDAQ: CTIC) has been one littered with speed bumps and potholes yet the biotechnology company now sits just a few months away from potentially clearing the final hurdle and advancing their … Continue reading
Allezoe Medical Holdings, Inc. (OTCBB: ALZM) Finding it Hard to Convince Investors about HPV Technology while LifeCradle Technology Remains on Life Support
Investors that are considering taking a position in Allezoe Medical Holdings, Inc. (OTCBB: ALZM) based on their recent announcements detailing their agreement to acquire patent pending technology that would enable healthcare providers to “see and treat” Human Papillomavirus (HPV) and … Continue reading
Will Questions Concerning Benefit-Risk Slow FDA Approval of Seattle Genetics (NASDAQ: SGEN) Cancer Drug Adcetris?
After 14 long years it looks as if Seattle Genetics (NASDAQ: SGEN) is now less than two months away from receiving its first FDA approval. Having taken a giant step on Tuesday following a relatively benign overview offered by the … Continue reading
BrainStorm Cell Therapeutics (OTCBB: BCLI) Share Price and Volume Jump on Research Analyst Report Despite Absence of Revenue and Products
Take a company like BrainStorm Cell Therapeutics (OTCBB: BCLI), which has been trading around the 0.25 – 0.30 with minimal volume over the past several months, throw in a “Buy” recommendation from a research analyst that predicts share price to … Continue reading